NASDAQ:IMAB
Delisted

I-mab Stock Signals

etoro logo Buy IMAB
*Your capital is at risk
$4.63
+0 (+0%)
At Close: Apr 14, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for I-Mab

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $4.63 0 %
Performance History
7 Days
$4.63 $4.63
0%
30 Days
$4.63 $4.63
0%
12 Mos
$0.96 $4.63
384.46%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 39.86
Signal Type Signal Value Importance Data
High / Low N/A Very Low $4.63 - $4.63
Trend - 3 mos 2.01 % High Width: 24.96 %
Pred. range - 3 mos $3.83 - $4.78 Low -17.33 % - 3.31 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Apr 13, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Feb 03, 2026 - 49 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Buy Medium Jan 20, 2026 - 59 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 74.41
Signal Type Signal Value Importance Data
Trend - 12 mos 83.38 % Very High Width: 121.98 %
Pred. range - 12 mos $6.97 - $15.48 High 50.60 % - 234.30 %
Short MA 12 mos Buy Very High Jan 13, 2026 - 63 days
Long MA 12 mos Buy Very High Jan 13, 2026 - 63 days
Short/Long MA 12 mos Buy Very High Feb 06, 2026 - 46 days
Pivot Long Sell Low Apr 13, 2026 - 2 days
RSI Long Pivot Signal Sell Low Feb 12, 2026 - 42 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT I-MAB
I-Mab
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinical trials to treat pediatric growth hormone deficiency; TJ107, a recombinant human IL-7, which is in Pha...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE